Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure
NCT00225901
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Liver Failure, Acute
Interventions
DRUG:
Recombinant human hepatocyte growth factor
Sponsor
Kyoto University, Graduate School of Medicine